390 related articles for article (PubMed ID: 33429210)
1. The discovery of Q-markers of Qiliqiangxin Capsule, a traditional Chinese medicine prescription in the treatment of chronic heart failure, based on a novel strategy of multi-dimensional "radar chart" mode evaluation.
He L; Liu Y; Yang K; Zou Z; Fan C; Yao Z; Dai Y; Li K; Chen J; Yao X
Phytomedicine; 2021 Feb; 82():153443. PubMed ID: 33429210
[TBL] [Abstract][Full Text] [Related]
2. Research on Q-markers of Qiliqiangxin capsule for chronic heart failure treatment based on pharmacokinetics and pharmacodynamics association.
Zhang F; Zhang Y; Li X; Zhang S; Zhu M; Du W; Xiao X
Phytomedicine; 2018 May; 44():220-230. PubMed ID: 29699844
[TBL] [Abstract][Full Text] [Related]
3. Development of a three-step-based novel strategy integrating DMPK with network pharmacology and bioactivity evaluation for the discovery of Q-markers of traditional Chinese medicine prescriptions: Danlou tablet as an example.
Wang Q; Chen G; Chen X; Liu Y; Qin Z; Lin P; Shang H; Ye M; He L; Yao Z
Phytomedicine; 2023 Jan; 108():154511. PubMed ID: 36334388
[TBL] [Abstract][Full Text] [Related]
4. Systematic screening and characterization of Qi-Li-Qiang-Xin capsule-related xenobiotics in rats by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
Yun WJ; Yao ZH; Fan CL; Qin ZF; Tang XY; Gao MX; Dai Y; Yao XS
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1090():56-64. PubMed ID: 29787993
[TBL] [Abstract][Full Text] [Related]
5. An integrated approach to discriminate the quality markers of Traditional Chinese medicine preparation based on multi-dimensional characteristic network: Shenqi Jiangtang Granule as a case.
Zhang H; Chen R; Xu C; Zhang G; Guan Y; Feng Q; Yao J; Yan J
J Ethnopharmacol; 2021 Oct; 278():114277. PubMed ID: 34089811
[TBL] [Abstract][Full Text] [Related]
6. Discrimination and identification of Q-markers based on 'Spider-web' mode for quality control of traditional Chinese medicine.
Jiang Z; Yang J; Wang Y
Phytomedicine; 2018 May; 44():98-102. PubMed ID: 29373247
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST).
Yao W; Cheang I; Liao S; Zhou Y; Zhou F; Xu D; Jia Z; Chang L; Zhang H; Li X
BMC Complement Med Ther; 2020 Feb; 20(1):38. PubMed ID: 32024496
[TBL] [Abstract][Full Text] [Related]
8. Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME prediction and network target analysis.
Guo R; Zhang X; Su J; Xu H; Zhang Y; Zhang F; Li D; Zhang Y; Xiao X; Ma S; Yang H
Phytomedicine; 2018 May; 44():117-128. PubMed ID: 29526583
[TBL] [Abstract][Full Text] [Related]
9. Screening the Q-markers of TCMs from RA rat plasma using UHPLC-QTOF/MS technique for the comprehensive evaluation of Wu-Wei-Wen-Tong Capsule.
Jiang H; Liu J; Wang Y; Chen L; Liu H; Wang Z; Wang B
J Mass Spectrom; 2021 May; 56(5):e4711. PubMed ID: 33764633
[TBL] [Abstract][Full Text] [Related]
10. Discovery of processing-associated Q-marker of carbonized traditional Chinese medicine: An integrated strategy of metabolomics, systems pharmacology and in vivo high-throughput screening model.
Gao M; Lan J; Zhang Y; Yu S; Bao B; Yao W; Cao Y; Shan M; Cheng F; Zhang L; Chen P
Phytomedicine; 2022 Jul; 102():154152. PubMed ID: 35636167
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potential Q-marker of traditional Chinese medicine based on plant metabolomics and network pharmacology: Periplocae Cortex as an example.
Li ZT; Zhang FX; Fan CL; Ye MN; Chen WW; Yao ZH; Yao XS; Dai Y
Phytomedicine; 2021 May; 85():153535. PubMed ID: 33819766
[TBL] [Abstract][Full Text] [Related]
12. Qiliqiangxin Attenuates Oxidative Stress-Induced Mitochondrion-Dependent Apoptosis in Cardiomyocytes via PI3K/AKT/GSK3β Signaling Pathway.
Zhao Q; Li H; Chang L; Wei C; Yin Y; Bei H; Wang Z; Liang J; Wu Y
Biol Pharm Bull; 2019 Aug; 42(8):1310-1321. PubMed ID: 31142701
[TBL] [Abstract][Full Text] [Related]
13. A novel and comprehensive strategy for quality control in complex Chinese medicine formula using UHPLC-Q-Orbitrap HRMS and UHPLC-MS/MS combined with network pharmacology analysis: Take Tangshen formula as an example.
Wang X; Zhou W; Wang Q; Zhang Y; Ling Y; Zhao T; Zhang H; Li P
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1183():122889. PubMed ID: 34626904
[TBL] [Abstract][Full Text] [Related]
14. Thrombin-based discovery strategy of bioactive-chemical quality marker combination for pollen of Typha orientalis by metabolomics coupled with chemometrics.
Wang X; Chen X; Li J; Evans OB; Wang H; Yang X; He J; Gao XM; Chang YX
Phytomedicine; 2020 Aug; 75():153246. PubMed ID: 32510336
[TBL] [Abstract][Full Text] [Related]
15. Selection and evaluation of quality markers from Yinlan capsule and its LXRα-mediated therapy for hyperlipidemia.
Chen Z; Sun D; Bi X; Luo W; Xu A; Chen W; Jiang J; Cai D; Guo H; Cao L
Phytomedicine; 2019 Jun; 59():152896. PubMed ID: 30978649
[TBL] [Abstract][Full Text] [Related]
16. From quality markers to data mining and intelligence assessment: A smart quality-evaluation strategy for traditional Chinese medicine based on quality markers.
Bai G; Zhang T; Hou Y; Ding G; Jiang M; Luo G
Phytomedicine; 2018 May; 44():109-116. PubMed ID: 29426601
[TBL] [Abstract][Full Text] [Related]
17. Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules.
Leung AYL; Chen H; Jia Z; Li X; Shen J
Chin Med; 2021 Oct; 16(1):103. PubMed ID: 34656145
[TBL] [Abstract][Full Text] [Related]
18. An integrated approach to uncover quality markers of Traditional Chinese medicine underlying chemical profiling, network target selection and metabolomics approach: Guan-Xin-Jing capsule as a model.
Zhang G; Wang Q; Liu X; Wang X; Xie W; Liu K; Jiang W; Mu C; Qi H; Wang Q
J Pharm Biomed Anal; 2020 Oct; 190():113413. PubMed ID: 32781322
[TBL] [Abstract][Full Text] [Related]
19. Quality markers based on biological activity: A new strategy for the quality control of traditional Chinese medicine.
Wu X; Zhang H; Fan S; Zhang Y; Yang Z; Fan S; Zhuang P; Zhang Y
Phytomedicine; 2018 May; 44():103-108. PubMed ID: 29506773
[TBL] [Abstract][Full Text] [Related]
20. Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
Packer M
Eur J Heart Fail; 2023 Dec; 25(12):2130-2143. PubMed ID: 37877337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
